Vyjuvek

Generic name: Beremagene-geperpavec-svdt
Dosage form: Topical gel
Drug class: Miscellaneous topical agents

Usage of Vyjuvek

Vyjuvek (beremagene-geperpavec-svdt) is a topical vector-based gene therapy that may be used to treat wounds in patients aged 6 months of age and older with dystrophic epidermolysis bullosa (DEB). It corrects the underlying skin defect of DEB by restoring functional copies of the COL7A1 gene to express COL7 and reassembling the anchoring fibrils that bind the dermis to the epidermis.

DEB is a serious, rare, genetic disorder that is one of four inherited forms of Epidermolysis Bullosa. It is caused by one or more mutations in the COL7A1 gene, resulting in the lack of production of functional type VII collagen (COL7) protein. The COL7 protein forms anchoring fibrils necessary to bind the dermis (inner layer of the skin) to the epidermis (outer layer of the skin). When there are no anchoring fibrils, the skin becomes extremely fragile, with minor friction or trauma (such as putting on a shirt) causing blisters and tears. Areas of the body primarily affected include the hands, feet, knees, and elbows.

Symptoms of DEB include open wounds, which lead to recurrent skin infections and fibrosis that can cause fusion of fingers and toes, and an increased risk of developing an aggressive form of squamous cell carcinoma (SCC).

Vyjuvek was approved on May 19, 2023, and is the first treatment for DEB to be approved by the FDA.

Vyjuvek side effects

Vyjuvek is well tolerated and common side effects include itching, chills, redness, rash, cough, and runny nose. In clinical trials, there were no drug-related serious adverse events or discontinuations due to treatment-related events.

To report suspected adverse reactions, contact Krystal Biotech, Inc. at 1-844-557-9782 or FDA at 1-800-FDA-1088 or http://www.fda.gov/medwatch.

Relate drugs

How to use Vyjuvek

Vyjuvek is a topical gel that is applied by a healthcare provider to the wounds of patients with DEB once a week, either in the home or a healthcare setting. Once the gel is mixed with the biological suspension, the gel is dotted evenly over the wound in a grid-like pattern (1cm by 1cm apart) and then covered with a dressing.

The weekly dose that can be applied depends on the age of the patient.

6 months to <3 years: 1.6 x 109 PFU or 0.8mL of reconstituted gel

3 years and older: 3.2 x 109 PFU or 1.6mL of reconstituted gel.

The amount needed per wound depends on the size of the wound.

Wound area (cm2) Dose (PFU) Volume (mL) <20 4 x 108 0.2 20 to <40 8 x 108 0.4 40 to <60 1.2 x 109 0.6

Vyjuvek can be re-dosed weekly as needed.

Warnings

There are no contraindications to the use of Vyjuvek.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.